Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients
暂无分享,去创建一个
[1] D. Aronoff,et al. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[2] N. Beeching,et al. Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium difficile Infection Recurrence: A Prospective Cohort Study , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] N. Matsuno,et al. Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[4] J. Ballard,et al. Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile , 2013, Microbiology and Molecular Reviews.
[5] C. Huff,et al. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] J. Mehta,et al. Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] K. Sepkowitz,et al. Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report , 2012, Infection Control & Hospital Epidemiology.
[8] R. Porcher,et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] T. Peto,et al. Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] C. Huff,et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] O. Dekkers,et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. , 2012, The Journal of antimicrobial chemotherapy.
[12] A. Zinsmeister,et al. The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study , 2012, The American Journal of Gastroenterology.
[13] G. Dumyati,et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] G. Alangaden,et al. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation , 2011, Clinical transplantation.
[15] J. Patterson,et al. Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection , 2010, The American journal of the medical sciences.
[16] D. Gerding,et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.
[17] J. Dipersio,et al. Clostridium difficile‐associated disease in allogeneic hematopoietic stem‐cell transplant recipients: risk associations, protective associations, and outcomes , 2010, Clinical transplantation.
[18] Stuart Johnson. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. , 2009, The Journal of infection.
[19] K. Garey,et al. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. , 2008, The Journal of hospital infection.
[20] M. Restrepo,et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma , 2006, Bone Marrow Transplantation.
[21] D. Milligan,et al. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.
[22] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[23] J. Klein,et al. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.